Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI

Katrina M Ingley
Katrina M Ingley
Sally M Burtenshaw
Sally M Burtenshaw
Nicole C Theobalds
Nicole C Theobalds
Rebecca A Gladdy
Rebecca A Gladdy
Seng Thipphavong
Seng Thipphavong

Cancer medicine, 2019.

Cited by: 0|Bibtex|Views0|Links
WOS
Keywords:
MR imagingT2 signalaggressive fibromatosisdesmoid fibromatosismethotrexate/vinorelbine chemotherapyMore(1+)

Abstract:

Low-dose MTX/VNL for a defined duration has high efficacy with sustained benefit and minimal toxicity for treating DF. V and T2 signal might better predict treatment response than RECIST.

Code:

Data:

Your rating :
0

 

Tags
Comments